BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 7969176)

  • 1. Cyclin A/CDK2 binds directly to E2F-1 and inhibits the DNA-binding activity of E2F-1/DP-1 by phosphorylation.
    Xu M; Sheppard KA; Peng CY; Yee AS; Piwnica-Worms H
    Mol Cell Biol; 1994 Dec; 14(12):8420-31. PubMed ID: 7969176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation of E2F-1 by cyclin A-cdk2.
    Kitagawa M; Higashi H; Suzuki-Takahashi I; Segawa K; Hanks SK; Taya Y; Nishimura S; Okuyama A
    Oncogene; 1995 Jan; 10(2):229-36. PubMed ID: 7838523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p130 and p107 use a conserved domain to inhibit cellular cyclin-dependent kinase activity.
    Woo MS; Sánchez I; Dynlacht BD
    Mol Cell Biol; 1997 Jul; 17(7):3566-79. PubMed ID: 9199292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formation of the early-region-2 transcription-factor-1-retinoblastoma-protein (E2F-1-RB) transrepressor and release of the retinoblastoma protein from nuclear complexes containing cyclin A is induced by interferon alpha in U937V cells but not in interferon-alpha-resistant U937VR cells.
    Kirch HC; Putzer B; Brockmann D; Esche H; Kloke O
    Eur J Biochem; 1997 Jun; 246(3):736-44. PubMed ID: 9219533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and activity of the retinoblastoma protein (pRB)-family proteins, p107 and p130, during L6 myoblast differentiation.
    Kiess M; Gill RM; Hamel PA
    Cell Growth Differ; 1995 Oct; 6(10):1287-98. PubMed ID: 8845306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific regulation of E2F family members by cyclin-dependent kinases.
    Dynlacht BD; Moberg K; Lees JA; Harlow E; Zhu L
    Mol Cell Biol; 1997 Jul; 17(7):3867-75. PubMed ID: 9199321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E2F/p107 and E2F/p130 complexes are regulated by C/EBPalpha in 3T3-L1 adipocytes.
    Timchenko NA; Wilde M; Iakova P; Albrecht JH; Darlington GJ
    Nucleic Acids Res; 1999 Sep; 27(17):3621-30. PubMed ID: 10446255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Rb-related p107 protein can suppress E2F function independently of binding to cyclin A/cdk2.
    Smith EJ; Nevins JR
    Mol Cell Biol; 1995 Jan; 15(1):338-44. PubMed ID: 7799940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C/EBPalpha regulates formation of S-phase-specific E2F-p107 complexes in livers of newborn mice.
    Timchenko NA; Wilde M; Darlington GJ
    Mol Cell Biol; 1999 Apr; 19(4):2936-45. PubMed ID: 10082561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of cdk2 and cdk3 on the control of pRb and E2F function during G1 exit.
    Hofmann F; Livingston DM
    Genes Dev; 1996 Apr; 10(7):851-61. PubMed ID: 8846921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A role for a p21-E2F interaction during senescence arrest of normal human fibroblasts.
    Afshari CA; Nichols MA; Xiong Y; Mudryj M
    Cell Growth Differ; 1996 Aug; 7(8):979-88. PubMed ID: 8853893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of E2F transcription by cyclin E-Cdk2 kinase mediated through p300/CBP co-activators.
    Morris L; Allen KE; La Thangue NB
    Nat Cell Biol; 2000 Apr; 2(4):232-9. PubMed ID: 10783242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p21 Disrupts the interaction between cdk2 and the E2F-p130 complex.
    Shiyanov P; Bagchi S; Adami G; Kokontis J; Hay N; Arroyo M; Morozov A; Raychaudhuri P
    Mol Cell Biol; 1996 Mar; 16(3):737-44. PubMed ID: 8622674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functions of cyclin A1 in the cell cycle and its interactions with transcription factor E2F-1 and the Rb family of proteins.
    Yang R; Müller C; Huynh V; Fung YK; Yee AS; Koeffler HP
    Mol Cell Biol; 1999 Mar; 19(3):2400-7. PubMed ID: 10022926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Site-directed mutant p21 proteins defective in both inhibition of E2F-regulated transcription and disruption of E2F-p130-cyclin-cdk2 complexes.
    Robles SJ; Shiyanov P; Aristodemo GT; Raychaudhuri P; Adami GR
    DNA Cell Biol; 1998 Jan; 17(1):9-18. PubMed ID: 9468218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2.
    Kitagawa M; Higashi H; Jung HK; Suzuki-Takahashi I; Ikeda M; Tamai K; Kato J; Segawa K; Yoshida E; Nishimura S; Taya Y
    EMBO J; 1996 Dec; 15(24):7060-9. PubMed ID: 9003781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner.
    Lees E; Faha B; Dulic V; Reed SI; Harlow E
    Genes Dev; 1992 Oct; 6(10):1874-85. PubMed ID: 1398067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SU9516, a cyclin-dependent kinase 2 inhibitor, promotes accumulation of high molecular weight E2F complexes in human colon carcinoma cells.
    Yu B; Lane ME; Wadler S
    Biochem Pharmacol; 2002 Oct; 64(7):1091-100. PubMed ID: 12234612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cdk2-dependent and -independent pathways in E2F-mediated S phase induction.
    Arata Y; Fujita M; Ohtani K; Kijima S; Kato JY
    J Biol Chem; 2000 Mar; 275(9):6337-45. PubMed ID: 10692433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MyoD prevents cyclinA/cdk2 containing E2F complexes formation in terminally differentiated myocytes.
    Puri PL; Balsano C; Burgio VL; Chirillo P; Natoli G; Ricci L; Mattei E; Graessmann A; Levrero M
    Oncogene; 1997 Mar; 14(10):1171-84. PubMed ID: 9121766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.